Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ricard Cervera, Munther A. Khamashta, Josep Font, Gerardo Ramirez, David D'cruz, Javier Montalban, Alfons Lopez-Soto, Ronald A. Asherson, Miguel Ingelmo & Graham R.V. Hughes. (1991) Antiendothelial Cell Antibodies in Patients with the Antiphospholipid Syndrome. Autoimmunity 11:1, pages 1-6.
Read now
Read now
Articles from other publishers (69)
Alfonso-Ragnar Torres-Jimenez, Virginia Ramirez-Nova, Adriana Ivonne Cespedes-Cruz, Berenice Sanchez-Jara, Alejandra Velazquez-Cruz, Vilma Carolina Bekker-Méndez & Francisco Xavier Guerra-Castillo. (2022) Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence. Pediatric Rheumatology 20:1.
Crossref
Crossref
Filipe F. Martins & Teresa M. L. Campos. (2021) Evaluation of Frequency, Clinical Correlation, and Antibodies Confirmation Profile in Patients with Suspected Antiphospholipid Syndrome. TH Open 05:04, pages e470-e478.
Crossref
Crossref
Paul R.J. Ames, Mira Merashli, Tommaso Bucci, Daniele Pastori, Pasquale Pignatelli, Alessia Arcaro & Fabrizio Gentile. (2020) Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 21:11, pages 4120.
Crossref
Crossref
Maria G Tektonidou, Laura Andreoli, Marteen Limper, Angela Tincani & Michael M Ward. (2019) Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults. RMD Open 5:1, pages e000924.
Crossref
Crossref
Mark Goodfield & Shyamal Wahie. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
3
.
R Cervera, R Serrano, G J Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, E de Ramón, V Buonaiuto, S Jacobsen, M M Zeher, T Tarr, A Tincani, M Taglietti, G Theodossiades, E Nomikou, M Galeazzi, F Bellisai, P L Meroni, R H W M Derksen, P G D de Groot, M Baleva, M Mosca, S Bombardieri, F Houssiau, J-C Gris, I Quéré, E Hachulla, C Vasconcelos, A Fernández-Nebro, M Haro, Z Amoura, M Miyara, M Tektonidou, G Espinosa, M L Bertolaccini & M A Khamashta. (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Annals of the Rheumatic Diseases 74:6, pages 1011-1018.
Crossref
Crossref
Gentian Denas & Vittorio Pengo. 2015. Antiphospholipid Antibody Syndrome. Antiphospholipid Antibody Syndrome
127
150
.
Nand K. Singh, Dibya R. Behera, Ankit Agrawal, Mahendra Narayan Singh, Vikash Kumar, Manoj Godhra, Anurag Gupta, Devesh P. Yadav, Usha Singh, Lakshmi Kant Pandey & Manjari Matah. (2013) Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome. International Journal of Rheumatic Diseases 16:5, pages 547-555.
Crossref
Crossref
R Cervera, MG Tektonidou, G Espinosa, AR Cabral, EB González, D Erkan, S Vadya, HE Adrogué, M Solomon, G Zandman-Goddard & Y Shoenfeld. (2011) Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations. Lupus 20:2, pages 174-181.
Crossref
Crossref
Young-Joon YangGak-Won YunIk-Chan SongSeung-Woo BaekKyu-Seop LeeHye Won RyuMyung-Won LeeHyo-Jin LeeHwan-Jung YunSamyong KimDeog-Yeon Jo. (2011) Clinical Implications of Elevated Antiphospholipid Antibodies in Adult Patients with Primary Immune Thrombocytopenia. The Korean Journal of Internal Medicine 26:4, pages 449.
Crossref
Crossref
Taraneh Mehrani & Michelle Petri. 2009. Antiphospholipid Syndrome in Systemic Autoimmune Diseases. Antiphospholipid Syndrome in Systemic Autoimmune Diseases
13
34
.
Manuel Ramos-CasalsPilar Brito-ZerónAlfonso López-Soto. (2008) Autoimmune diseases in the elderly: systemic lupus erythematosus and Sjögren’s syndrome. Aging Health 4:4, pages 389-397.
Crossref
Crossref
Rossana Mejía-Romero, Mario García-Carrasco, Claudio Galarza-Maldonado, Pedro Santos, Claudia Mendoza-Pinto, Ricardo O. Escárcega, Salvador Salinas-Saldivar, Elena Soto-Vega, Aurelio López-Colombo & Ricard Cervera. (2007) Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients. Clinical Rheumatology 27:7, pages 891-897.
Crossref
Crossref
M. García-Carrasco, C. Galarza, M. Gómez-Ponce, R. Cervera, J. Rojas-Rodríguez, G. EspinosaS. Bucciarelli, J.A. Gómez-Puerta, A. Bové, R.O. Escárcega & J. Font. (2016) Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients. Lupus 16:5, pages 366-373.
Crossref
Crossref
Ljudmila Stojanovich. (2006) Pulmonary manifestations in antiphospholipid syndrome. Autoimmunity Reviews 5:5, pages 344-348.
Crossref
Crossref
Charles Mackworth-Young. (2006) Primary antiphospholipid syndrome: A distinct entity?. Autoimmunity Reviews 5:1, pages 70-75.
Crossref
Crossref
Tonia L. Vincent & Charles G. Mackworth-Young. 2006. Hughes Syndrome. Hughes Syndrome
155
170
.
Jean-Charles Piette & Beverley J. Hunt. 2006. Hughes Syndrome. Hughes Syndrome
117
126
.
L J JaraG Medina, O Vera-Lastra & L Barile. (2016) The impact of gender on clinical manifestations of primary antiphospholipid syndrome. Lupus 14:8, pages 607-612.
Crossref
Crossref
Francisco Carmona, Josep Font, Isabel Moga, Isabel Làzaro, Ricard Cervera, Visitación Pac & Juan Balasch. (2005) Class III-IV Proliferative Lupus Nephritis and Pregnancy: A Study of 42 Cases. American Journal of Reproductive Immunology 53:4, pages 182-188.
Crossref
Crossref
Ricard CERVERA, Josep FONT, Francisco CARMONA & Juan BALASCH. (2004) Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. APLAR Journal of Rheumatology 7:3, pages 263-267.
Crossref
Crossref
Massimo Breccia, Gianna Maria D'Elia, Gabriella Girelli, Stefania Vaglio, Fabiana Gentilini, Sarlo Chiara & Giuliana Alimena. (2004) Paroxysmal cold haemoglobinuria as a tardive complication of idiopathic myelofibrosis. European Journal of Haematology 73:4, pages 304-306.
Crossref
Crossref
María Teresa Camps García, Antonio Fernández Nebro, Carolina Díaz Cobos, Manuel Haro Liger, Miguel Ángel Barón Ramos & Enrique de Ramón Garrido. (2004) Manifestaciones clínicas y alteraciones inmunológicas en pacientes con síndrome antifosfolipídico. Presentación de 112 casos. Medicina Clínica 123:12, pages 466-470.
Crossref
Crossref
Manuel Ramos-Casals, Pilar Brito-Zerón, Alfonso López-Soto & Josep Font. (2004) Systemic autoimmune diseases in elderly patients:. Autoimmunity Reviews 3:5, pages 376-382.
Crossref
Crossref
Gerard Espinosa, Ricard Cervera, Mario Garcı́a-Carrasco, Josep Font & Ronald A Asherson. 2004. Pulmonary involvement in systemic autoimmune diseases. Pulmonary involvement in systemic autoimmune diseases
137
145
.
M Ramos-CasalsM García-Carrasco, M P Brito, A López-Soto & J Font. (2016) Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus 12:5, pages 341-355.
Crossref
Crossref
P Soltész, K Veres, G LakosE Kiss, L Muszbek & G Szegedi. (2016) Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients. Lupus 12:4, pages 302-307.
Crossref
Crossref
Doruk Erkan, Mary J. Roman, Felicia Tenedios & Michael D. Lockshin. 2003. The Hearth in Systemic Autoimmune Diseases. The Hearth in Systemic Autoimmune Diseases
213
225
.
Ricard Cervera, Josep Font, Francisco Carmona & Juan Balasch. (2002) Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium. Autoimmunity Reviews 1:6, pages 354-359.
Crossref
Crossref
J BalaschR Cervera. (2016) Reflections on the management of reproductive failure in the antiphospholipid syndrome—the clinician’s perspective. Lupus 11:8, pages 467-477.
Crossref
Crossref
Ricard Cervera, Jean‐Charles Piette, Josep Font, Munther A. Khamashta, Yehuda Shoenfeld, María Teresa Camps, Soren Jacobsen, Gabriella Lakos, Angela Tincani, Irene Kontopoulou‐Griva, Mauro Galeazzi, Pier Luigi Meroni, Ronald H. W. M. Derksen, Philip G. de Groot, Erika Gromnica‐Ihle, Marta Baleva, Marta Mosca, Stefano Bombardieri, Frédéric Houssiau, Jean‐Christophe Gris, Isabelle Quéré, Eric Hachulla, Carlos Vasconcelos, Beate Roch, Antonio Fernández‐Nebro, Marie‐Claire Boffa, Graham R. V. Hughes & Miguel Ingelmo. (2002) Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis & Rheumatism 46:4, pages 1019-1027.
Crossref
Crossref
G. Espinosa, R. Cervera & J. Font. (2002) El pulmón en el síndrome antifosfolipídico. Archivos de Bronconeumología 38:1, pages 27-32.
Crossref
Crossref
Cristina Drenkard & Donato Alarcón-Segovia. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II
409
419
.
Juan Balasch, Francisco Carmona, Montserrat Creus, Josep Font & Ricard Cervera. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II
375
394
.
Lisa R. Sammaritano & Jean-Charles Piette. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II
297
316
.
Ronald A. Asherson, Jean-Charles Piette & Ricard Cervera. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II
285
296
.
Francisco Carmona & Juan Balasch. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II
205
211
.
Gerard Espinosa, Ricard Cervera, Josep Font, Mario García-Carrasco, Carlos Battagliotti & Miguel Ingelmo. 2002. The Antiphospholipid Syndrome II. The Antiphospholipid Syndrome II
169
188
.
Mary-Carmen Amigo. (2001) PROGNOSIS IN ANTIPHOSPHOLIPID SYNDROME. Rheumatic Disease Clinics of North America 27:3, pages 661-669.
Crossref
Crossref
F D Juengling, J Kassubek & S M Weiner. (2016) Cerebral glucose metabolism in Sneddon's syndrome associated with antiphospholipid antibodies. Lupus 10:4, pages 309-310.
Crossref
Crossref
Yasuo ONTATI, Eisaku ASAKURA, Tomoe MIZUTANI, minori KATO, Takako ITO, Masahide YAMAZAKI, Eriko MORISHITA, Tomotaka YOSHIDA, Masanori SAITO, Keiji AOSHIMA, Shinji MINAMI & Shinji NAKAO. (2001) . Japanese Journal of Thrombosis and Hemostasis 12:6, pages 493-499.
Crossref
Crossref
Wendell A Wilson. (2000) Ethnicity and APS. Journal of Autoimmunity 15:2, pages 153-155.
Crossref
Crossref
M Weber, G Hayem, M DeBandt, E Palazzo, S Roux, M-F Kahn & O Meyer. (2016) The family history of patients with primary or secondary antiphospholipid syndrome (APS). Lupus 9:4, pages 258-263.
Crossref
Crossref
Yaniv Sherer, Avi Livneh, Yair Levy, Yehuda ShoenfeldPnina Langevitz. (2016) Dermatomyositis and polymyositis associated with the antiphospholipid syndrome—a novel overlap syndrome. Lupus 9:1, pages 42-46.
Crossref
Crossref
G. Díaz Moya, M. Cantalejo Moreira & E. Martín Mola. (2000) Síndrome antifosfolípido. Medicine - Programa de Formación Médica Continuada Acreditado 8:29, pages 1514-1519.
Crossref
Crossref
J.M. Ribera, M. Vaquero, Joan Altet, Raúl Ortega & Felip Vilardell. (2000) Mujer de 87 años con mal estado general, fiebre, hepatomegalia y hemofagocitosis. Medicina Clínica 115:16, pages 630-636.
Crossref
Crossref
J. Font & R. Cervera. 2000. Hughes Syndrome. Hughes Syndrome
32
42
.
T. Vincent & C. Mackworth-Young. 2000. Hughes Syndrome. Hughes Syndrome
111
126
.
J.-C. Piette & B. J. Hunt. 2000. Hughes Syndrome. Hughes Syndrome
96
104
.
Camille Francès, Thomas Papo, Bertrand Wechsler, Jean-Luc Laporte, Valérie Biousse & Jean-Charles Piette. (1999) Sneddon Syndrome with or without Antiphospholipid Antibodies: A Comparative Study in 46 Patients. Medicine 78:4, pages 209-219.
Crossref
Crossref
Francisco Carmona, José Font, Ricard Cervera, Francisco Muñoz, Vicente Cararach & Juan Balasch. (1999) Obstetrical outcome of pregnancy in patients with systemic Lupus Erythematosus. A study of 60 cases. European Journal of Obstetrics & Gynecology and Reproductive Biology 83:2, pages 137-142.
Crossref
Crossref
SILVIA STERLA, HIROSHI SATO & ALBERTO NIETO. (1999) Echinococcus granulosus human infection stimulates low avidity anticarbohydrate IgG2 and high avidity antipeptide IgG4 antibodies. Parasite Immunology 21:1, pages 27-34.
Crossref
Crossref
Dimitrios Karussis, Ronen R. Leker, Avi Ashekenazi & Oded Abramsky. (2004) A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?. Annals of Neurology 44:4, pages 629-634.
Crossref
Crossref
Jean-Charles PiettePatrice Cacoub. (1998) Antiphospholipid Syndrome in the Elderly: Caution. Circulation 97:22, pages 2195-2196.
Crossref
Crossref
JT Lie. (2016) Vasculopathy of the Antiphospholipid Syndromes Revisited: Thrombosis is the Culprit and Vasculitis the Consort. Lupus 5:5, pages 368-371.
Crossref
Crossref
Eli Zuckerman, Elias Toubi, Avinoam Shiran, Edmund Sabo, Zehava Shmuel, Theo Dov Golan, Edward Abinader & Daniel Yeshurun. (1996) Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: A controlled prospective study. The American Journal of Medicine 101:4, pages 381-386.
Crossref
Crossref
JT Merrill & RG Lahita. (2016) The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?. Lupus 5:1, pages 6-10.
Crossref
Crossref
Isamu IKEDA, Shuichi HIGASHI, Masayoshi JOHNO, Kumiko MIZUTARI & Tomomichi ONO. (1996) Three Cases of Anticardiolipin Antibody Syndrome. Nishi Nihon Hifuka 58:3, pages 382-386.
Crossref
Crossref
S.Nahum Goldberg, Ann Marie Conti-Kelly & Thomas P. Greco. (1995) A family study of anticardiolipin antibodies and associated clinical conditions. The American Journal of Medicine 99:5, pages 473-479.
Crossref
Crossref
Juan Balasch & José Font. (2016) Antiphospholipid Antibody Testing in Patients with Pregnancy Loss. Lupus 3:5, pages 429-431.
Crossref
Crossref
Ronald A. Asherson & Ricard Cervera. (2016) 'Primary', 'Secondary' and Other Variants of the Antiphospholipid Syndrome. Lupus 3:4, pages 293-298.
Crossref
Crossref
Donato Alarcon-Segovia. (2016) Antiphospholipid Syndrome Within Systemic Lupus Erythematosus. Lupus 3:4, pages 289-291.
Crossref
Crossref
Jean-Charles Piette. (2016) Prevention of Recurrent Thrombosis in the Antiphospholipid Syndrome. Lupus 3:2, pages 73-74.
Crossref
Crossref
Joao L. Vianna, Munther A. Khamashta, Jose Ordi-Ros, Jose Font, Ricard Cervera, Alfonso Lopez-Soto, Carlos Tolosa, Juliane Franz, Alberto Selva, Miguel Ingelmo, Miguel Vilardell & Graham R.V. Hughes. (1994) Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. The American Journal of Medicine 96:1, pages 3-9.
Crossref
Crossref
Ronald A. Asherson & Ricard Cervera. (1993) Antiphospholipid Syndrome.. Journal of Investigative Dermatology 100:1, pages 21S-27S.
Crossref
Crossref
Ronald A. Asherson & Ricard Cervera. (1993) Antiphospholipid Syndrome. Journal of Investigative Dermatology 100:1, pages S21-S27.
Crossref
Crossref
B Eber. (1992) Antiphospholipid antibodies and the heart.. Circulation 85:6, pages 2332-2332.
Crossref
Crossref
Ricard Cervera, Munther A. Khamashta, Josep Font, Pedro A. Reyes, João L. Vianna, Alfons López-Soto, Mary-Carmen Amigo, Ronald A. Asherson, Manuel Azqueta, Carles Paré, Jesús Vargas, Angel Romero, Miguel Ingelmo & Graham R.V. Hughes. (2016) High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome. Lupus 1:1, pages 43-47.
Crossref
Crossref
R A Asherson & R Cervera. (1991) Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist.. Circulation 84:2, pages 920-923.
Crossref
Crossref